United States - English - NLM (National Library of Medicine)

bryant ranch prepack - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa inc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg

United States - English - NLM (National Library of Medicine)

cardinal health - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

egis pharmaceuticals plc - methyldopa (methyldopa sesquihydrate) - tablets - 250mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

egis pharmaceuticals plc - methyldopa (methyldopa sesquihydrate) - tablets - 250mg (50) in glass container

United States - English - NLM (National Library of Medicine)

chartwell rx, llc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see warnings ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (mao) inhibitors.

Kenya - English - Pharmacy and Poisons Board

national pharmacy ltd p.o box 17843-00500 - methyldopa - tablet - 250mg - methyldopa (levorotatory)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa -